F-1/A: Haoxi Health Files Amendment No. 5 to Form F-1 for Updated Consents and Articles

Sentiment:

Form F-1/A Amendment


Haoxi Health Technology Limited files an amendment to its Form F-1 registration statement to include updated consents from its auditor and revised memorandum and articles of association.

Capital raiseThe document is related to a registration statement, which is a precursor to a potential capital raise through an initial public offering (IPO).

Summary

  • Haoxi Health Technology Limited has filed Amendment No. 5 to its Form F-1 registration statement.
  • The amendment is primarily to file an updated consent of Wei, Wei & Co., LLP as Exhibit 23.1.
  • It also includes the Company's Fourth Amended and Restated Memorandum and Articles of Association as Exhibits 3.1 and 3.2, respectively.
  • The exhibit index in Part II of the Registration Statement has been amended and restated.
  • The filing includes information on indemnification of directors and officers, recent sales of unregistered securities, and exhibits.
  • The Fourth Amended and Restated Memorandum of Association was adopted on November 22, 2023, and states the company's name, registered office, unrestricted objects, and share capital structure.
  • The Fourth Amended and Restated Articles of Association, also adopted on November 22, 2023, detail definitions, share issuance, transfer, meetings, voting rights, director appointments, and other corporate governance matters.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing, indicating progress towards a potential IPO. The sentiment is neutral to slightly positive as it reflects necessary steps for the company's growth.

Positives

  • The filing of updated consents and articles of association is a necessary step for the company's registration statement to become effective.
  • The articles of association provide a detailed framework for corporate governance and shareholder rights.

Future Outlook

The document does not contain specific forward-looking statements regarding financial performance or business operations beyond the registration process.

Industry Context

This filing is a standard step for companies seeking to list their securities in the United States, ensuring compliance with SEC regulations and providing updated information to potential investors.

Comparison to Industry Standards

  • The two-class share structure with differential voting rights is a common feature among technology companies seeking to maintain founder control after going public, similar to companies like Google (Alphabet Inc.) and Facebook (Meta Platforms, Inc.).
  • The indemnification agreements for directors and officers are standard practice to attract and retain qualified individuals, aligning with practices seen in companies such as Apple Inc. and Microsoft Corp.
  • The detailed articles of association covering various corporate governance aspects are comparable to those of other publicly listed companies, ensuring transparency and accountability to shareholders.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
AmendmentFiling of Fourth Amended and Restated Memorandum and Articles of AssociationNovember 22, 2023Updates the company's governing documents to reflect current practices and legal requirements.

Stakeholder Impact

  • Shareholders: The filing is a step towards a potential IPO, which could provide liquidity and value appreciation.
  • Employees: A successful IPO could lead to increased company value and potential benefits.
  • Potential Investors: The registration statement provides information for making informed investment decisions.

Next Steps

  • The company will likely proceed with the registration process, addressing any further comments from the SEC.
  • Following effectiveness of the registration statement, the company may proceed with its initial public offering.

Key Dates

DateDescription
August 25, 2023Original filing date of the Registration Statement on Form F-1 (Registration No. 333-274214)
October 24, 2023Date of Wei, Wei & Co., LLP's audit report on the consolidated financial statements of Haoxi Health Technology Limited and Subsidiaries
November 22, 2023Date of adoption of the Fourth Amended and Restated Memorandum and Articles of Association
January 23, 2024Filing date of Amendment No. 5 to Form F-1

Keywords

Form F-1, registration statement, amendment, Haoxi Health Technology, Wei, Wei & Co., memorandum of association, articles of association, Class A shares, Class B shares, corporate governance, indemnification, unregistered securities

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.